These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21386825)

  • 1. Discovery of a linear peptide for improving tumor targeting of gene products and treatment of distal tumors by IL-12 gene therapy.
    Cutrera J; Dibra D; Xia X; Hasan A; Reed S; Li S
    Mol Ther; 2011 Aug; 19(8):1468-77. PubMed ID: 21386825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy of anaplastic thyroid carcinoma with a single-chain interleukin-12 fusion protein.
    Shi Y; Parhar RS; Zou M; Baitei E; Kessie G; Farid NR; Alzahrani A; Al-Mohanna FA
    Hum Gene Ther; 2003 Dec; 14(18):1741-51. PubMed ID: 14670125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of tumor growth and induction of long-term antitumor memory by interleukin 12 electro-gene therapy.
    Li S; Zhang X; Xia X
    J Natl Cancer Inst; 2002 May; 94(10):762-8. PubMed ID: 12011227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12 gene therapy is an effective therapeutic strategy for hepatocellular carcinoma in immunosuppressed mice.
    Harada N; Shimada M; Okano S; Suehiro T; Soejima Y; Tomita Y; Maehara Y
    J Immunol; 2004 Dec; 173(11):6635-44. PubMed ID: 15557154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin directs the accumulation of interleukin-12 induced IFN gamma into tumors for enhancing STAT1 dependent antitumor effect.
    Zhu S; Waguespack M; Barker SA; Li S
    Clin Cancer Res; 2007 Jul; 13(14):4252-60. PubMed ID: 17634555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination nonviral interleukin 2 and interleukin 12 gene therapy for head and neck squamous cell carcinoma.
    Li D; Shugert E; Guo M; Bishop JS; O'Malley BW
    Arch Otolaryngol Head Neck Surg; 2001 Nov; 127(11):1319-24. PubMed ID: 11701067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of experimental breast cancer using interleukin-12 gene therapy combined with anti-vascular endothelial growth factor receptor-2 antibody.
    Rakhmilevich AL; Hooper AT; Hicklin DJ; Sondel PM
    Mol Cancer Ther; 2004 Aug; 3(8):969-76. PubMed ID: 15299079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intricacies for posttranslational tumor-targeted cytokine gene therapy.
    Cutrera J; Dibra D; Satelli A; Xia X; Li S
    Mediators Inflamm; 2013; 2013():378971. PubMed ID: 24369443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of murine hepatocellular carcinoma using genetically modified cells to express interleukin-12.
    Peron JM; Couderc B; Rochaix P; Douin-Echinard V; Asnacios A; Souque A; Voigt JJ; Buscail L; Vinel JP; Favre G
    J Gastroenterol Hepatol; 2004 Apr; 19(4):388-96. PubMed ID: 15012775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination radiation and gene therapy for head and neck squamous cell carcinoma in the murine model].
    Liu SX; Yang H; Yuan YM; Guo YF; Tang ZQ; Liang CY
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 May; 39(5):278-82. PubMed ID: 15338865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-12 gene therapy prevents establishment of SCC VII squamous cell carcinomas, inhibits tumor growth, and elicits long-term antitumor immunity in syngeneic C3H mice.
    Myers JN; Mank-Seymour A; Zitvogel L; Storkus W; Clarke M; Johnson CS; Tahara H; Lotze MT
    Laryngoscope; 1998 Feb; 108(2):261-8. PubMed ID: 9473079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of combined gene therapy expressing constitutive human GM-CSF and hyperthermia-regulated human IL-12.
    Wei F; Wang H; Zhang J; Chen X; Li C; Huang Q
    J Exp Clin Cancer Res; 2013 Jan; 32(1):5. PubMed ID: 23352035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of interleukin 12 and interferon alpha gene therapy induces a synergistic antitumor response against colon and renal cell carcinoma.
    Mendiratta SK; Quezada A; Matar M; Thull NM; Bishop JS; Nordstrom JL; Pericle F
    Hum Gene Ther; 2000 Sep; 11(13):1851-62. PubMed ID: 10986558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors.
    Zhu S; Lee DA; Li S
    J Immunol; 2010 Mar; 184(5):2348-54. PubMed ID: 20139275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined GM-CSF and IL-12 gene therapy synergistically suppresses the growth of orthotopic liver tumors.
    Chang CJ; Chen YH; Huang KW; Cheng HW; Chan SF; Tai KF; Hwang LH
    Hepatology; 2007 Mar; 45(3):746-54. PubMed ID: 17326190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of antitumor activity of a single-chain interleukin-12 IgG3 antibody fusion protein (mscIL-12.her2.IgG3).
    Peng LS; Penichet ML; Dela Cruz JS; Sampogna SL; Morrison SL
    J Interferon Cytokine Res; 2001 Sep; 21(9):709-20. PubMed ID: 11576465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine gene therapy of mesothelioma. Immune and antitumor effects of transfected interleukin-12.
    Caminschi I; Venetsanakos E; Leong CC; Garlepp MJ; Robinson BW; Scott B
    Am J Respir Cell Mol Biol; 1999 Sep; 21(3):347-56. PubMed ID: 10460752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral delivery of interleukin 12 expression plasmids with in vivo electroporation is effective for colon and renal cancer.
    Tamura T; Nishi T; Goto T; Takeshima H; Dev SB; Ushio Y; Sakata T
    Hum Gene Ther; 2001 Jul; 12(10):1265-76. PubMed ID: 11440620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cationic liposome mediated delivery of FUS1 and hIL-12 coexpression plasmid demonstrates enhanced activity against human lung cancer.
    Ren J; Yu C; Wu S; Peng F; Jiang Q; Zhang X; Zhong G; Shi H; Chen X; Su X; Luo X; Zhu W; Wei Y
    Curr Cancer Drug Targets; 2014; 14(2):167-80. PubMed ID: 24410728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Cell-Surface Vimentin (CSV) as a Sarcoma Target and Development of CSV-Targeted IL12 Immune Therapy.
    Batth IS; Li S
    Adv Exp Med Biol; 2020; 1257():169-178. PubMed ID: 32483739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.